FDA orders blindness risk warning on weight loss drugs
- Newsrooms
- 6
- Last 3 hours
- 0 reports
- Momentum
- Quiet
0 in the 3 before
Cooling
Reports per hour, last 24 hours
How the coverage splits
Against the past week
More newsrooms than 91% of the past week’s 3579 stories, and number 15 of 271 in Tech.Part of a bigger story
Ozempic: 4 developments since Mon 9 Nov.Related
GLP-1 Jabs Linked to Scary Side Effect That’s Worse Than ‘Ozempic Face’ (shares GLP-1 and Ozempic)The Food and Drug Administration now requires warning labels on Ozempic, Wegovy and other GLP-1 drugs over a rare eye condition tied to vision loss.
Sky News didn’t include a summary, so this is Fox Business’s, from its report on the same story.2
The bigger story: Ozempic
4 developments since Mon 9 Nov. 2 more since this one.
FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
You’re here6 newsrooms. Linked by Wegovy, Ozempic, drug, pose, risk, weight
- WA study reveals lifting weights is crucial to preserving muscle when taking weight-loss drugs like Ozempic
1 newsroom. Linked by Ozempic, study, weight, drug
- Weight loss drugs, such as Ozempic, to carry FDA warning about rare vision-loss side effects
1 newsroom. Linked by Ozempic, FDA, weight, drug, carry, rare
The story so far
6 newsroomsCooling- Reports
- 6
- Newsrooms and sources
- 6
- Last 3 hours
- 0
Cooling: well below its busiest stretch (0 in the last three hours, 0 in the three before).
First with it: Gizmodo, 2 hr 37 min before anyone else.
Reported by 6 newsrooms.
The numbers behind it
How it spread, where it’s heading and where the coverage is from
Reports a day, last 7 days
| Day | Stories |
|---|---|
| Thu | 0 |
| Fri | 0 |
| Sat | 0 |
| Sun | 0 |
| Mon | 0 |
| Tue | 4 |
| Today | 2 |
Where the coverage is from
How it spread
Newsrooms reporting it, each counted at its first report.
This headline has dropped off the live wire. The link above still goes to the original story.